Clinical Trial Update: Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) [Phase 2]

View source ↗

Summary

Phase 2 randomized open-label trial evaluating inhaled ciclesonide for patients with COVID-19 (HALT COVID-19).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia Viral
• Sars-cov-2

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: Ola Blennow, MD, PhD | Conditions: Covid-19, Pneumonia, Viral | Phase 2 | Status: UNKNOWN